The NZSO is excited to return to Auckland for the 49th edition of our annual scientific meeting.
This year, the conference will be held on a weekend to better accommodate those colleagues with clinical duties. We are also pleased to announce that, for the first time, NZSO will be contiguous with a major whole-day symposium on progress in breast cancer research and medicine. Further details on this exciting event, which is being coordinated by Breast Cancer Cure and will feature leading international speakers, are given below.
NZSO 2017 focuses on continuing to improve the scientific program and conference experience offered to our delegates. Confirmed session themes include immuno-oncology, radiation sciences and medicine, molecular pathology and diagnostics, drug discovery, early-phase clinical trials and genomics. Keep an eye out for announcements concerning training sessions, networking events and opportunities for trainees to meet with our distinguished guests.
Finally, we anticipate the announcement of our prestigious Bruce Cain Memorial Lectureship, Translational Research Award, Roche Translational Cancer Research Fellowship and PHARMAC Trainee Awards. A nomination process has been implemented for the Translational Research Award and is now open for submissions – further information can be found here
We look forward to seeing you in Auckland.
Ben Lawrence, NZSO President
Breast Cancer: Priorities for improved survival and optimising outcomes
Symposium to be held on 13 October 2017, Crowne Plaza, Auckland
In association with the NZSO 2017 Annual Meeting
The purpose of the day will be to discuss how current and future research can change the lives of breast cancer patients, through better prevention, earlier detection and deeper molecular knowledge of individual patients' tumours to guide their therapy.
The day will involve influential international and local speakers and will be both stimulating and educational. It will offer those working in the field: oncologists, scientists, health professionals, regulators and consumers a unique opportunity to discuss our current state of knowledge, future research opportunities and what our priorities are for improving survival and optimising outcomes.
For enquiries, please contact Phillipa Green: email@example.com